image image image image
HHV-6 antibody level correlates with relapse and progression in MS patients Anti-HHV-6 IgG titer may be a useful prognostic factor in predicting relapsing-remitting MS clinical course
Read the Full Story
HHV-6 reactivation predicts graft failure in cord blood transplant patients HHV-6 reactivation before engraftment strongly predictive of graft failure
Read the Full Story
Baylor’s immunotherapy technique found effective in a small clinical trial Trial explores immunotherapy for opportunistic viruses in transplantation
Read the Full Story
Pityriasis rosea, HHV-6, and the increased risk of miscarriage Italian study finds 62% of women who developed PR early in their pregnancies miscarried
Read the Full Story
1 2 3 4

Featured News

  • 1
  • 2
  • 3

Latest HHV-6 Research

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8

Repository of Reagents

Reagents for conducting HHV-6 & 7 research are available through the HHV-6 Foundation Repository

Learn More

About the Foundation

The HHV-6 Foundation in a non-profit entity founded to encourage scientific exchange between investigators and to provide pilot grants for promising scientific and clinical research on the under- appreciated viruses HHV-6A and HHV-6B. The Foundation sponsors international conferences and supports scientists and clinicians seeking to clarify the role of the two HHV-6 viruses in disease. Since the HHV-6A and HHV-6B can smolder in the brain and other organs without circulating in the peripheral blood or plasma, identifying chronic infection is a challenge. Read More

ciHHV-6 Patient Registry

Except for transplant patients, HHV-6 plasma DNA tests are rarely positive. Any patient testing positive should rule out chromosomally integrated HHV-6, a condition that may be associated with increased HHV-6 reactivation.

Join now

Website development by inStyle Technologies